Clinical Study
Expanded Access Treatment with Open-Label Pegunigalsidase Alfa for Fabry Patients
Expanded Access Treatment with Open-Label Pegunigalsidase Alfa for Fabry Patients.
For more information contact:
Carrie Bailey
carrie.bailey@hsc.utah.edu
801-587-3605
IRB#: IRB_00140105
| PI: Nicola Longo
| Department: PEDIATRIC GENETICS
| Approval Date: 2021-04-07 06:00:00
Specialties: Pediatric Genetics
Who can participate?
Gender: All
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?
No